Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON registered -TB Gold (+) Kenyan adults wit... by Walsh, Douglas S, Owira, Victorine, Polhemus, Mark, Otieno, Lucas, Andagalu, Ben, Ogutu, Bernhards, Waitumbi, John, Hawkridge, Anthony, Shepherd, Barbara, Pau, Maria Grazia, Sadoff, Jerald, Douoguih, Macaya, McClain, JBruce

Get full text

Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked... by McLean, Chelsea, Barry, Houreratou, Kieh, Mark, Anywaine, Zacchaeus, Tapima Rogers, Baimba, Doumbia, Seydou, Sirima, Sodiomon B., Serry-Bangura, Alimamy, Habib Beavogui, Abdoul, Gaddah, Auguste, Katwere, Michael, Hendriks, Jenny, Keshinro, Babajide, Eholie, Serge, Kibuuka, Hannah, Kennedy, Stephen B., Anzala, Omu, Samai, Mohamed, D'Ortenzio, Eric, Leigh, Bailah, Sow, Samba, Thiébaut, Rodolphe, Greenwood, Brian, Watson-Jones, Deborah, Douoguih, Macaya, Luhn, Kerstin, Robinson, Cynthia

Get full text

Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON® -TB Gold (+) Kenyan adults without evide... by Walsh, Douglas S, Owira, Victorine, Polhemus, Mark, Otieno, Lucas, Andagalu, Ben, Ogutu, Bernhards, Waitumbi, John, Hawkridge, Anthony, Shepherd, Barbara, Pau, Maria Grazia, Sadoff, Jerald, Douoguih, Macaya, McClain, J. Bruce

Get full text

LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A R... by Falsey, Ann R, Williams, Kristi, Gymnopoulou, Efi, Bart, Stephan A, Ervin, John E, Bastian, Arangassery Rosemary, Menten, Joris, De Paepe, Els, de Boer, Hilde, Vandenberghe, Sjoukje, Chan, Eric, Sadoff, Jerald, Douoguih, Macaya, Callendret, Benoit, Comeaux, Christy, Heijnen, Esther

Get full text

LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials by Le Gars, Mathieu, Sadoff, Jerald, Jongeneelen, Mandy, Heerwegh, Dirk, Shukarev, Georgi, Truyers, Carla, de Groot, Anne Marit, Scheper, Gert, Hendriks, Jenny, Brandenburg, Boerries, Struyf, Frank, Van Hoof, Johan, Douoguih, Macaya, Schuitemaker, Hanneke

Get full text

AERAS-402/Ad35 vaccine induces CD4+ and CD8+ responses in HIV-infected, BCG-vaccinated adults (P4487) by Hokey, David, Pandian, Ramanan, Graves, Andrew, Churchyard, Gavin, Snowden, Peggy, Douoguih, Macaya, Landry, Bernard

Get full text

Durable natural killer cell responses after heterologous two-dose Ebola vaccination: NPJ Vaccines by Wagstaffe, Helen R., Susannini, Giada, Thiébaut, Rodolphe, Richert, Laura, Lévy, Yves, Bockstal, Viki, Stoop, Jeroen N., Luhn, Kerstin, Douoguih, Macaya, Riley, Eleanor M, Lacabaratz, Christine, Goodier, Martin R

Get full text

The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3 by Churchyard, Gavin John, Snowden, Margaret Ann, Hokey, David, Dheenadhayalan, Veerabadran, McClain, J. Bruce, Douoguih, Macaya, Pau, Maria Grazia, Sadoff, Jerry, Landry, Bernard

Get full text

High mortality rates for very low birth weight infants in developing countries despite training by Carlo, Waldemar A, Goudar, Shivaprasad S, Jehan, Imtiaz, Chomba, Elwyn, Tshefu, Antoinette, Garces, Ana, Parida, Sailajanandan, Althabe, Fernando, McClure, Elizabeth M, Derman, Richard J, Goldenberg, Robert L, Bose, Carl, Hambidge, Michael, Panigrahi, Pinaki, Buekens, Pierre, Chakraborty, Hrishikesh, Hartwell, Tyler D, Moore, Janet, Wright, Linda L

Get full text

1049. Minimal Transient HIV-1 Viremia Following Vaccination Regimens Containing AD26. ZEBOV and MVA-BN-Filo in ART-Suppressed People Living with HIV by Custer, Benjamin L, Mwesigwa, Betty, Sawe, Fredrick, Oyieko, Janet, Ntinginya, Nyanda, Jani, Ilesh, Iroezindu, Michael, Hutter, Jack, Jagodzinski, Linda, Shukarev, Georgi, Eller, Leigh Anne, Ward, Lucy, Overman, Rachel, Rusnak, Janice M, Bounds, Callie, Badorrek, Christopher, Polyak, Christina, Esber, Allahna L, Moodley, Amber D, Tran, Chi, Gaddah, Auguste, Luhn, Kerstin, Douoguih, Macaya, Robinson, Cynthia, Ake, Julie A

Get full text

Heterologous prime-boost with Ad35/AERAS-402 and MVA85A elicits potent CD8+ T cell immune responses in a phase I clinical trial (VAC7P.969) by Hokey, David, O'Dee, Dawn, Graves, Andrew, Douoguih, Macaya, Pau, Maria, Versteege, Isabella, Sheehan, Sharon, Harris, Stephanie, Landry, Bernard, Sadoff, Jerald, McShane, Helen

Get full text

Safety and immunogenicity of the Ad35/AERAS-402 tuberculosis vaccine in a phase 2 dose-finding clinical trial in BCG-vaccinated healthy infants (VAC5P.1119) by Hokey, David, Tameris, Michele, Henson, Dawn, Dheenadhayalan, Veerabadran, Blatner, Gretta, McClain, Bruce, Walker, Robert, Hatherill, Mark, Nduba, Videlis, Sacarlal, Jahit, Gray, Glenda, Hendriks, Jenny, Pau, Maria, Douoguih, Macaya, Sadoff, Jerald, Barker, Lewellys

Get full text

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered i... by Viki Bockstal, Georgi Shukarev, Chelsea McLean, Neil Goldstein, Stephan Bart, Auguste Gaddah, Dickson Anumenden, Jeroen N Stoop, Anne Marit de Groot, Maria G Pau, Jenny Hendriks, Stephen C De Rosa, Kristen W Cohen, M Juliana McElrath, Benoit Callendret, Kerstin Luhn, Macaya Douoguih, Cynthia Robinson

Get full text

Adenoviral-vectored tuberculosis vaccine AERAS-402 enhances T cell cytokine response in TB+ patients. (VAC12P.1026) by Graves, Andrew, van Zyl-Smit, Richard, Esmail, Ali, Bateman, Mary, Dawson, Rodney, Goldin, Jonathan, van Rikxoort, Eva, Douoguih, Macaya, Pau, Maria, Sadoff, Jerald, Bennett, Sean, Snowden, Margaret, Gearhart, Jacqueline, Ishmukhamedov, Sadritdin, Schrager, Lewis, McClain, J., Bateman, Eric, Hokey, David

Get full text

Consensus Statement on Diagnostic End Points for Infant Tuberculosis Vaccine Trials by Hatherill, Mark, Verver, Suzanne, Mahomed, Hassan

Get full text

A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust... by Hokey, David A, Wachholder, Robert, Darrah, Patricia A, Bolton, Diane L, Barouch, Dan H, Hill, Krystal, Dheenadhayalan, Veerabadran, Schwander, Stephan, Godin, C Steven, Douoguih, Macaya, Pau, Maria Grazia, Seder, Robert A, Roederer, Mario, Sadoff, Jerald C, Sizemore, Donata

Get full text

Heterologous Prime-Boost Schedules of Replication-Defective Adenovirus Serotype 26 and Modified Vaccinia Virus Ankara Vector Vaccines Expressing Ebola Virus Glycoprotein Are Immuno... by Milligan, Iain, Gibani, Malick, Campbell, Danielle, Clutterbuck, Elizabeth, Sewell, Richard, Plested, Emma, Nuthall, Elizabeth, Voysey, Merryn, Quintana, Nicola Orzabal De La, Shukarev, Georgi, Truyers, Carla, Duijnhoven, Wilbert Van, Luhn, Kerstin, Douoguih, Macaya, Ewer, Katie, Hill, Adrian V. S., Angus, Brian, Pollard, Andrew J., Snape, Matthew

Get full text

744Heterologous Prime-Boost Schedules of Replication-Defective Adenovirus Serotype 26 and Modified Vaccinia Virus Ankara Vector Vaccines Expressing Ebola Virus Glycoprotein Are Imm... by Milligan, Iain, Gibani, Malick, Campbell, Danielle, Clutterbuck, Elizabeth, Sewell, Richard, Plested, Emma, Nuthall, Elizabeth, Voysey, Merryn, Quintana, Nicola Orzabal De La, Shukarev, Georgi, Truyers, Carla, Duijnhoven, Wilbert Van, Luhn, Kerstin, Douoguih, Macaya, Ewer, Katie, Hill, Adrian V. S., Angus, Brian, Pollard, Andrew J., Snape, Matthew

Request full text